European wide survey on allogeneic haematopoietic cell transplantation practice for myelofibrosis on behalf of the EBMT chronic malignancies working party

McLornan, 2019, State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019, Haematologica, 104, 659, 10.3324/haematol.2018.206151

Kröger, 2015, Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group, Leukemia, 29, 2126, 10.1038/leu.2015.233

McLornan, 2019, Myeloablative and reduced-intensity conditioned allogeneic hematopoietic stem cell transplantation in myelofibrosis: a retrospective study by the chronic malignancies working party of the european society for blood and marrow transplantation, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant., 25, 2167, 10.1016/j.bbmt.2019.06.034

McLornan, 2018, Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT, Br J Haematol, 182, 418, 10.1111/bjh.15407

Robin, 2017, The impact of splenectomy in myelofibrosis patients before allogeneic hematopoietic stem cell transplantation, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant., 23, 958, 10.1016/j.bbmt.2017.03.002

Cervantes, 2009, New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment, Blood, 113, 2895, 10.1182/blood-2008-07-170449

Passamonti, 2010, A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment), Blood, 115, 1703, 10.1182/blood-2009-09-245837

Gangat, 2011, DIPSS plus: a refined dynamic international prognostic scoring system for primary myelofibrosis that incorporates prognostic information from Karyotype, platelet count, and transfusion status, J Clin Oncol, 29, 392, 10.1200/JCO.2010.32.2446

Tefferi, 2018, MIPSS70+ version 2.0: mutation and karyotype-enhanced international prognostic scoring system for primary myelofibrosis, J Clin Oncol Off J Am Soc Clin Oncol, 36, 1769, 10.1200/JCO.2018.78.9867

Guglielmelli, 2018, MIPSS70: mutation-enhanced international prognostic score system for transplantation-age patients with primary myelofibrosis, J Clin Oncol, 36, 310, 10.1200/JCO.2017.76.4886

Grinfeld, 2018, Classification and personalized prognosis in Myeloproliferative Neoplasms, N Engl J Med, 379, 1416, 10.1056/NEJMoa1716614

Passamonti, 2017, A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis, Leukemia, 31, 2726, 10.1038/leu.2017.169

Ali, 2019, MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen, Blood Adv, 3, 83, 10.1182/bloodadvances.2018026658

Kröger, 2018, Peritransplantation ruxolitinib prevents acute graft-versus-Host disease in patients with myelofibrosis undergoing allogenic stem cell transplantation, Biol Blood Marrow Transplant, 24, 2152, 10.1016/j.bbmt.2018.05.023